Contamination by hepatitis B and C viruses in the dialysis setting

Nicola Froio, Emanuele Nicastri, Ubaldo Visco Comandini, Chiara Cherubini, Roberto Felicioni, Mariacarmela Solmone, Salvatore Di Giulio, Nicola Petrosillo

Research output: Contribution to journalArticle

Abstract

Background: Hepatitis virus infections continue to be a major concern in the dialysis setting. We studied levels of hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) RNA contamination in dialysis units to better define the role of the dialysis environment and machines in the nosocomial transmission of hepatitis viruses. Methods: Possible contamination by hepatitis B virus (HBV) and HCV was studied by collecting environmental samples in 3 dialysis units located in Rome, Italy. Samples and controls were tested for HBsAg by a microparticle enzyme immunoassay, and for HCV RNA, by qualitative transcription-mediated amplification assay, Results: HCV RNA and HBsAg were detected in 1 of 64 (1.6%) and 1 of 64 samples (1.6%), respectively. The only HCV RNA-positive sample was found in 1 dialysis unit on the external surface of the dialysate (inlet-outlet) connector of a dialysis machine used for HCV-negative patients. The only HBsAg-positive sample was found in another dialysis unit on the internal surface of the blood pressure monitor cuff of a dialysis bed dedicated for HBsAg-positive patients. Conclusion: A segregation policy for HBsAg-positive patients is a necessary measure despite its high cost-effectiveness; we found HBsAg contamination in the segregated HBV-infected room. Conversely, the finding of HCV RNA contamination on a dialysis machine not dedicated to HCV-positive patients suggests that isolation of HCV-infected dialysis patients and use of dedicated machines are unjustified. Major attention should be given to strict adherence to infection control measures in the dialysis setting.

Original languageEnglish
Pages (from-to)546-550
Number of pages5
JournalAmerican Journal of Kidney Diseases
Volume42
Issue number3
DOIs
Publication statusPublished - Sep 1 2003

Fingerprint

Hepatitis B virus
Hepacivirus
Dialysis
Hepatitis B Surface Antigens
RNA
Hepatitis Viruses
Blood Pressure Monitors
Patient Isolation
Dialysis Solutions
Virus Diseases
Infection Control
Immunoenzyme Techniques
Italy
Cost-Benefit Analysis

Keywords

  • Contamination
  • Dialysis
  • Equipment
  • Hepatitis B surface antigen (HBsAg)
  • Hepatitis C virus (HCV)

ASJC Scopus subject areas

  • Nephrology

Cite this

Contamination by hepatitis B and C viruses in the dialysis setting. / Froio, Nicola; Nicastri, Emanuele; Comandini, Ubaldo Visco; Cherubini, Chiara; Felicioni, Roberto; Solmone, Mariacarmela; Di Giulio, Salvatore; Petrosillo, Nicola.

In: American Journal of Kidney Diseases, Vol. 42, No. 3, 01.09.2003, p. 546-550.

Research output: Contribution to journalArticle

Froio, Nicola ; Nicastri, Emanuele ; Comandini, Ubaldo Visco ; Cherubini, Chiara ; Felicioni, Roberto ; Solmone, Mariacarmela ; Di Giulio, Salvatore ; Petrosillo, Nicola. / Contamination by hepatitis B and C viruses in the dialysis setting. In: American Journal of Kidney Diseases. 2003 ; Vol. 42, No. 3. pp. 546-550.
@article{e6423f97511c40ecbb3b480243afb70d,
title = "Contamination by hepatitis B and C viruses in the dialysis setting",
abstract = "Background: Hepatitis virus infections continue to be a major concern in the dialysis setting. We studied levels of hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) RNA contamination in dialysis units to better define the role of the dialysis environment and machines in the nosocomial transmission of hepatitis viruses. Methods: Possible contamination by hepatitis B virus (HBV) and HCV was studied by collecting environmental samples in 3 dialysis units located in Rome, Italy. Samples and controls were tested for HBsAg by a microparticle enzyme immunoassay, and for HCV RNA, by qualitative transcription-mediated amplification assay, Results: HCV RNA and HBsAg were detected in 1 of 64 (1.6{\%}) and 1 of 64 samples (1.6{\%}), respectively. The only HCV RNA-positive sample was found in 1 dialysis unit on the external surface of the dialysate (inlet-outlet) connector of a dialysis machine used for HCV-negative patients. The only HBsAg-positive sample was found in another dialysis unit on the internal surface of the blood pressure monitor cuff of a dialysis bed dedicated for HBsAg-positive patients. Conclusion: A segregation policy for HBsAg-positive patients is a necessary measure despite its high cost-effectiveness; we found HBsAg contamination in the segregated HBV-infected room. Conversely, the finding of HCV RNA contamination on a dialysis machine not dedicated to HCV-positive patients suggests that isolation of HCV-infected dialysis patients and use of dedicated machines are unjustified. Major attention should be given to strict adherence to infection control measures in the dialysis setting.",
keywords = "Contamination, Dialysis, Equipment, Hepatitis B surface antigen (HBsAg), Hepatitis C virus (HCV)",
author = "Nicola Froio and Emanuele Nicastri and Comandini, {Ubaldo Visco} and Chiara Cherubini and Roberto Felicioni and Mariacarmela Solmone and {Di Giulio}, Salvatore and Nicola Petrosillo",
year = "2003",
month = "9",
day = "1",
doi = "10.1016/S0272-6386(03)00787-X",
language = "English",
volume = "42",
pages = "546--550",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Contamination by hepatitis B and C viruses in the dialysis setting

AU - Froio, Nicola

AU - Nicastri, Emanuele

AU - Comandini, Ubaldo Visco

AU - Cherubini, Chiara

AU - Felicioni, Roberto

AU - Solmone, Mariacarmela

AU - Di Giulio, Salvatore

AU - Petrosillo, Nicola

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Background: Hepatitis virus infections continue to be a major concern in the dialysis setting. We studied levels of hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) RNA contamination in dialysis units to better define the role of the dialysis environment and machines in the nosocomial transmission of hepatitis viruses. Methods: Possible contamination by hepatitis B virus (HBV) and HCV was studied by collecting environmental samples in 3 dialysis units located in Rome, Italy. Samples and controls were tested for HBsAg by a microparticle enzyme immunoassay, and for HCV RNA, by qualitative transcription-mediated amplification assay, Results: HCV RNA and HBsAg were detected in 1 of 64 (1.6%) and 1 of 64 samples (1.6%), respectively. The only HCV RNA-positive sample was found in 1 dialysis unit on the external surface of the dialysate (inlet-outlet) connector of a dialysis machine used for HCV-negative patients. The only HBsAg-positive sample was found in another dialysis unit on the internal surface of the blood pressure monitor cuff of a dialysis bed dedicated for HBsAg-positive patients. Conclusion: A segregation policy for HBsAg-positive patients is a necessary measure despite its high cost-effectiveness; we found HBsAg contamination in the segregated HBV-infected room. Conversely, the finding of HCV RNA contamination on a dialysis machine not dedicated to HCV-positive patients suggests that isolation of HCV-infected dialysis patients and use of dedicated machines are unjustified. Major attention should be given to strict adherence to infection control measures in the dialysis setting.

AB - Background: Hepatitis virus infections continue to be a major concern in the dialysis setting. We studied levels of hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) RNA contamination in dialysis units to better define the role of the dialysis environment and machines in the nosocomial transmission of hepatitis viruses. Methods: Possible contamination by hepatitis B virus (HBV) and HCV was studied by collecting environmental samples in 3 dialysis units located in Rome, Italy. Samples and controls were tested for HBsAg by a microparticle enzyme immunoassay, and for HCV RNA, by qualitative transcription-mediated amplification assay, Results: HCV RNA and HBsAg were detected in 1 of 64 (1.6%) and 1 of 64 samples (1.6%), respectively. The only HCV RNA-positive sample was found in 1 dialysis unit on the external surface of the dialysate (inlet-outlet) connector of a dialysis machine used for HCV-negative patients. The only HBsAg-positive sample was found in another dialysis unit on the internal surface of the blood pressure monitor cuff of a dialysis bed dedicated for HBsAg-positive patients. Conclusion: A segregation policy for HBsAg-positive patients is a necessary measure despite its high cost-effectiveness; we found HBsAg contamination in the segregated HBV-infected room. Conversely, the finding of HCV RNA contamination on a dialysis machine not dedicated to HCV-positive patients suggests that isolation of HCV-infected dialysis patients and use of dedicated machines are unjustified. Major attention should be given to strict adherence to infection control measures in the dialysis setting.

KW - Contamination

KW - Dialysis

KW - Equipment

KW - Hepatitis B surface antigen (HBsAg)

KW - Hepatitis C virus (HCV)

UR - http://www.scopus.com/inward/record.url?scp=0041358503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041358503&partnerID=8YFLogxK

U2 - 10.1016/S0272-6386(03)00787-X

DO - 10.1016/S0272-6386(03)00787-X

M3 - Article

C2 - 12955683

AN - SCOPUS:0041358503

VL - 42

SP - 546

EP - 550

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 3

ER -